Elucid Revenue and Competitors

Boston, MA USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Elucid's estimated annual revenue is currently $25.1M per year.(i)
  • Elucid's estimated revenue per employee is $251,000

Employee Data

  • Elucid has 100 Employees.(i)
  • Elucid grew their employee count by 20% last year.

Elucid's People

NameTitleEmail/Phone
1
FounderReveal Email/Phone
2
Chief StatisticianReveal Email/Phone
3
CEOReveal Email/Phone
4
CTO & SVP EngineeringReveal Email/Phone
5
VP PeopleReveal Email/Phone
6
VP Clinical DevelopmentReveal Email/Phone
7
VP EngineeringReveal Email/Phone
8
SVP Regulatory Affairs and Quality ManagementReveal Email/Phone
9
Director ProductReveal Email/Phone
10
Director MarketingReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$9.8M393%N/AN/A
#2
$8.5M343%N/AN/A
#3
$3M12-29%N/AN/A
#4
$5630M7477-11%$450MN/A
#5
$4.5M186%N/AN/A
#6
$7.2M5727%$29.6MN/A
#7
$14.3M57-12%N/AN/A
#8
$2.3M186%$44MN/A
#9
$40.7M162-1%N/AN/A
#10
$45.7M182-5%N/AN/A
Add Company

What Is Elucid?

Elucid Bioimaging is a medical technology company leveraging machine intelligence to improve the accuracy, experience, and cost-effectiveness of vascular diagnostic imaging. Its groundbreaking product, vascuCAP®, is the first FDA-cleared & CE-marked, histology-validated, non-invasive image analysis software for evaluating CTAs to provide multi-dimensional visualization, structural measurements, & plaque composition to inform risk of event (heart attack or stroke) and personalized treatment selection. vascuCAP® is in use by cardiologists, vascular surgeons, radiologists, and neurologists across the US and EU at health systems, clinics, and research institutes. vascuCAP® has applications for coronary, carotid, and peripheral arteries. In addition, Elucid also offers quantifying imaging services to evaluate the severity of vascular disease, in particular, atherosclerosis, and assess longitudinal therapeutic response to investigative therapeutic agents to vascular disease

keywords:N/A

N/A

Total Funding

100

Number of Employees

$25.1M

Revenue (est)

20%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Elucid News

2022-04-20 - Desarae Dee multimedia empire continues to flourish

Elucid Magazine is an active force in the fashion community. We unite the city's leading visionaries and artists under one editorial roof.

2022-04-06 - billy woods playing NYC release show; ELUCID too (with Soul Glo)

ELUCID has a new solo LP on the way too, called I Told Bessie, and he'll celebrate it with a release show on June 16 at Mercury Lounge,...

2022-04-06 - Soul Glo announce tour (including NYC w/ ELUCID, Philly w ...

... bands play NYC), and Soul Glo will come to NYC to open Armand Hammer member ELUCID's album release show on June 16 at Mercury Lounge.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$24.3M100-5%$52.8M
#2
$14M100-15%$35.5M
#3
$15M100-21%N/A
#4
$15M10016%N/A
#5
$15.5M1009%$210M